NCT04592159View on ClinicalTrials.gov

Study of the Safety and Efficacy of Nabiximols Oromucosal Spray Versus Placebo in Patients With Post-traumatic Stress Disorder

PHASE2/PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

February 1, 2021

Primary Completion Date

March 31, 2023

Study Completion Date

March 31, 2023

Conditions
Post-Traumatic Stress Disorder
Interventions
DRUG

Nabiximols

oromucosal spray

DRUG

Placebo

oromucosal spray

Sponsors
All Listed Sponsors
lead

Jazz Pharmaceuticals

INDUSTRY